Cadent Capital Advisors, LLC Merck & Co., Inc. Transaction History
Cadent Capital Advisors, LLC
- $317 Million
- Q3 2024
A detailed history of Cadent Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cadent Capital Advisors, LLC holds 2,136 shares of MRK stock, worth $206,252. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,136
Previous 2,713
21.27%
Holding current value
$206,252
Previous $335,000
27.76%
% of portfolio
0.08%
Previous 0.14%
Shares
8 transactions
Others Institutions Holding MRK
# of Institutions
3,820Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.1 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.5 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.32 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.71 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $245B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...